Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells

FASEB Journal

Volumn 15, Issue 6, 2001, Pages 995-1005

  Wartenberg, Maria ^a   Dönmez, Fatma ^a   Ling, Frederike C ^a   Acker, Helmut ^a,b   Hescheler, Jürgen ^a   Sauer, Heinrich ^a,c  

^a UNIVERSITY OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^c Department of Neurophysiology ^*  (Germany)

Author keywords

HSP27; Hypoxia; Multidrug resistance; P glycoprotein; VEGF

Indexed keywords

GLYCOPROTEIN P; HEAT SHOCK PROTEIN 27; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL HYPOXIA; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; STEM CELL; TUMOR VASCULARIZATION;

ANIMALS; COCULTURE TECHNIQUES; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; NUCLEAR PROTEINS; OXYGEN; SPHEROIDS, CELLULAR; STEM CELLS; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0035073872     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0350com     Document Type: Article

References (45)

1. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function
2. Angiogenesis: How a tumor adapts to hypoxia
3. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
4. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression
5. Oxygen sensing and signaling: Impact on the regulation of physiologically important genes
6. Inhibition of angiogenesis
7. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
8. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
9. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action
10. Glioma cell invasion visualized by scanning confocal laser microscopy in an in vitro co-culture system
11. Glioma cell interactions with fetal rat brain aggregates in vitro and with brain tissue in vivo
12. The embryoid body as a novel in vitro assay system for antiangiogenic agents
13. Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps
14. Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies
15. The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium
16. Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy
17. Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells
18. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy
19. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer
20. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker
21. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
22. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
23. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer
24. Cell and environment interactions in tumor microregions: The multicell spheroid model
25. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids
26. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the 'optical probe technique'
27. Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro
28. Co-expression of the MDR1 gene and HSP27 in human ovarian cancer
29. In acute myeloid leukemia, coexpression of at least two proteins, including P-glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat-shock protein 27, is predictive of the response to induction chemotherapy
30. Differentiation patterns in two- and three-dimensional culture systems of human squamous carcinoma cell lines
31. Hematopoietic commitment during embryonic stem cell differentiation in culture
32. Analysis of factors controlling primary germ layer formation and early hematopoiesis using embryonic stem cell in vitro differentiation
33. Interactions between bladder tumor cells as tumor spheroids from the cell line J82 and human endothelial cells in vitro
34. Interaction of human malignant melanoma tumor spheroids with endothelium and reconstituted basement membrane: Modulation by RGDS
35. Multicellular spheroids: A three-dimensional in vitro culture system to study tumour biology
36. Hypoxia and radiation response in human tumors
37. 2 predicts survival in advanced cancer of the uterine cervix
38. Blood flow, oxygen consumption and tissue oxygenation of human tumors
39. Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas
40. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism
41. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors
42. Hypoxia-induced drug resistance: Comparison to P-glycoprotein-associated drug resistance
43. Effect of transient hypoxia on sensitivity to doxorubicin in human and murine cell lines
44. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
45. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer